Novartis Announces Statistically Significant Reduction in Proteinuria with Fabhalta® in Phase III C3G Study
May 26, 2024
Clinicaltrial Investment Portfolios
AIM ImmunoTech Commences Key Study for Pancreatic Cancer Treatment in Partnership with AstraZeneca
Feb 15, 2024
BioNTech and DualityBio Start Key Phase 3 Trial for Metastatic Breast Cancer Treatment
Jan 23, 2024
SciSparc Embarks on a Phase IIb Trial of THC-Based Treatment for Tourette Syndrome
Nov 11, 2023